Propelled by the positive results of the limited commercial release of its second proprietary product line, Nextremity Solutions announces the full launch of the Re+Line(TM) Bunion Correction System in the United States.
Rod K. Mayer, President and CEO of Nextremity Solutions(R), commented “We are very pleased by the overwhelmingly favorable surgeon feedback on the versatility and stable fixation characteristics of Re+Line(TM). This is important to us given the multiple techniques utilized by forefoot surgeons in bunion correction surgery today. Consequently, we anticipate that Re+Line’s unique, low-profile, tension-band plate design will to continue to expand in its applications as we gain more market experience.
William von Brendel, EVP Global Marketing and International Sales of Nextremity Solutions(R), remarked “The combination of Nextra and Re+Line provides us a highly differentiated product presence in the two largest and fastest growing forefoot surgery segments. Additionally, the high rates of combined hammertoe and bunion surgery will provide important synergy to our growing best-in-class product portfolio.”
About Nextremity Solutions, Inc.
Nextremity Solutions(R) is a privately held medical device company offering novel solutions and approaches to forefoot surgical intervention. The Company’s procedure ready, sterile implant systems for the correction of forefoot pathologies include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.
For further information, visit www.nextremitysolutions.com or call 574-635-3023.
Nextra(R) Hammertoe Correction System, Nextra(R) Hammertoe Correction Implant, Precision Ready(R) Systems, Re+Line(TM) Bunion Correction System and Re+Line(TM) Bunion Correction Plate are trademarks of Nextremity Solutions, Inc.
